chromMAGMA: regulatory element-centric interrogation of risk variants
Robbin A. Nameki, Anamay H. Shetty, Eileen Dareng, Jonathan P. Tyrer, Xianzhi Lin, Paul D.P. Pharoah, Rosario I. Corona, Siddhartha Kar, Kate Lawrenson
chromMAGMA identifies candidate risk genes for epithelial ovarian cancer by mapping risk variants to noncoding regulatory elements, revealing new genes and pathways involved in the disease.
bioRxiv · Jan 21, 2022 · PreprintGenetics